NCT02102113View on ClinicalTrials.gov

Probing the Cannabinoid System in Individuals With a Family History of Psychosis

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
PsychosisCannabis UseTHCMarijuanaSchizophrenia
Interventions
DRUG

Placebo

placebo

DRUG

Very Low Dose THC

Subjects will receive 0.010mg/kg.

DRUG

Low Dose THC

Subjects will receive 0.018 mg/kg over 20 minutes.

Trial Locations (1)

06516

VA Connecticut Healthcare System, West Haven

All Listed Sponsors
lead

Yale University

OTHER